EFFICACY OF RUXOLITINIB IN MYELOID NEOPLASMS WITH PCM1-JAK2 FUSION GENE

被引：0
|
作者：
Casetti, I. C. [1 ]
Milosevic, J. D. [2 ]
Rumi, E. [3 ]
Selleslag, D. [4 ]
Lierman, E. [5 ]
Pietra, D. [3 ]
Cavalloni, C. [1 ]
Bellini, M. [1 ]
Milanesi, C. [3 ]
Astori, C. [3 ]
Kralovics, R. [2 ]
Vandenberghe, P. [5 ]
Cazzola, M. [1 ,3 ]
机构：
[1] IRCCS Policlin San Matteo, Dept Mol Med, Pavia, Italy
[2] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[3] IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy
[4] Acad Hosp St Jan, Dept Hematol, Brugge, Belgium
[5] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1342
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [1] Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
    Rumi, Elisa
    Milosevic, Jelena D.
    Selleslag, Dominik
    Casetti, Ilaria
    Lierman, Els
    Pietra, Daniela
    Cavalloni, Chiara
    Bellini, Marta
    Milanesi, Chiara
    Dambruoso, Irene
    Astori, Cesare
    Kralovics, Robert
    Vandenberghe, Peter
    Cazzola, Mario
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1927 - 1928
  • [2] Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
    Elisa Rumi
    Jelena D. Milosevic
    Dominik Selleslag
    Ilaria Casetti
    Els Lierman
    Daniela Pietra
    Chiara Cavalloni
    Marta Bellini
    Chiara Milanesi
    Irene Dambruoso
    Cesare Astori
    Robert Kralovics
    Peter Vandenberghe
    Mario Cazzola
    Annals of Hematology, 2015, 94 : 1927 - 1928
  • [3] Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated With a PCM1-JAK2 Fusion Gene
    Rumi, Elisa
    Milosevic, Jelena D.
    Casetti, Ilaria
    Dambruoso, Irene
    Pietra, Daniela
    Boveri, Emanuela
    Boni, Marina
    Bernasconi, Paolo
    Passamonti, Francesco
    Kralovics, Robert
    Cazzola, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : E269 - E271
  • [4] Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene
    Wouters, Yannick
    Nevejan, Louis
    Louwagie, Annelies
    Devos, Helena
    Dewaele, Barbara
    Selleslag, Dominik
    Michaux, Lucienne
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (04) : e112 - e115
  • [5] Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
    Juliana Schwaab
    Marcin Knut
    Claudia Haferlach
    Georgia Metzgeroth
    Hans-Peter Horny
    Andrew Chase
    William Tapper
    Joannah Score
    Katherine Waghorn
    Nicole Naumann
    Mohamad Jawhar
    Alice Fabarius
    Wolf-Karsten Hofmann
    Nicholas C. P. Cross
    Andreas Reiter
    Annals of Hematology, 2015, 94 : 233 - 238
  • [6] Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
    Schwaab, Juliana
    Knut, Marcin
    Haferlach, Claudia
    Metzgeroth, Georgia
    Horny, Hans-Peter
    Chase, Andrew
    Tapper, William
    Score, Joannah
    Waghorn, Katherine
    Naumann, Nicole
    Jawhar, Mohamad
    Fabarius, Alice
    Hofmann, Wolf-Karsten
    Cross, Nicholas C. P.
    Reiter, Andreas
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 233 - 238
  • [7] Limited duration of complete hematologic and cytogenetic remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
    Schwaab, J.
    Knut, M.
    Haferlach, C.
    Fabarius, A.
    Metzgeroth, G.
    Horny, H. -P
    Chase, A.
    Tapper, W.
    Score, J.
    Naumann, N.
    Gosenca, D.
    Jawhar, M.
    Fritsche, P.
    Hofmann, W. -K
    Cross, N. C.
    Reiter, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 219 - 219
  • [8] PCM1-JAK2 Fusion in a Patient With Acute Myeloid Leukemia
    Lee, Jong-Mi
    Lee, Jaewoong
    Han, Eunhee
    Kim, Myungshin
    Kim, Yonggoo
    Han, Kyungja
    Kim, Hee-Je
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (05) : 492 - 494
  • [9] Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia
    Metzgeroth, G.
    Schwaab, J.
    Naumann, N.
    Haferlach, C.
    Jawhar, M.
    Horny, H. -P.
    Dirk, J.
    Kratz-Albers, K.
    Kraemer, D.
    Mayer, S.
    Storch, N.
    Burchert, A.
    Haferlach, T.
    Cross, N. C. P.
    Hofmann, W. -K.
    Fabarius, A.
    Reiter, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [10] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Patterer, Verena
    Schnittger, Susanne
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    ANNALS OF HEMATOLOGY, 2013, 92 (06) : 759 - 769
12345